NASDAQ:MLEC • KYG6223S1259
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MOOLEC SCIENCE SA (MLEC).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-01-30 | Maxim Group | Initiate | Buy |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 905.1K | 5.868M 548.33% | 6.774M 15.44% | 8.806M 30.00% | 78.877M 795.72% | 133.39M 69.11% | 220.81M 65.54% | 418.47M 89.52% | |||
| EBITDA YoY % growth | -13.8K | -1.715M -12,327.54% | -6.532M -280.86% | -10.914M -67.09% | -9.792M 10.28% | -1.326M 86.46% | 16.014M 1,307.69% | 37.23M 132.48% | 68.238M 83.29% | 154.84M 126.91% | |
| EBIT YoY % growth | -13.8K | -1.717M -12,339.86% | -6.654M -287.59% | -8.753M -31.54% | -12.454M -42.29% | -11.731M 5.81% | 6.865M 158.52% | 24.98M 263.87% | 53.55M 114.37% | 136.47M 154.85% | |
| Operating Margin | N/A | N/A | -735.15% | -149.16% | -183.85% | -133.22% | 8.70% | 18.73% | 24.25% | 32.61% | |
| EPS YoY % growth | N/A | N/A | N/A | -29.07 93.52% | -0.27 97.75% | -0.24 7.69% | 0.04 116.67% | 0.20 400.00% | 0.46 125.00% | 1.18 157.78% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.06 84.70% | -0.07 99.32% |
| Revenue Q2Q % growth | 2.047M -2.99% | 2.05M 34.60% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -3.133M -0.89% | -3.334M -31.87% |
All data in USD
MOOLEC SCIENCE SA (MLEC) will report earnings on 2026-04-07.
The consensus EPS estimate for the next earnings of MOOLEC SCIENCE SA (MLEC) is -0.06 USD and the consensus revenue estimate is 2.05M USD.
The consensus rating for MOOLEC SCIENCE SA (MLEC) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.